Achaogen named Spotlight Leadership Company
Erie, PA: Outsourced Pharma San Francisco will feature Achaogen as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations (October 17 - 18 at the Hyatt Regency San Francisco Airport). The session is titled: Spotlight Leadership Company: Achaogen.
Panelists for this session include the following members of Achaogen’s technical operations organization: Kirin Jamison, Director, Antibody Process Development; Jim Kirchner, Senior Director, CMC; Tina Larson, VP, Technical Operations; Amelia Milani, Senior Director, Supply Chain. The panel will be moderated by Louis Garguilo, Chief Editor & Conference Chair, Outsourced Pharma.
Members of Achaogen will provide insight and advice on the successful outsourcing of various activities and functions. And they’ll take your questions on how they’ve achieved such success to date.
“We are excited to be on the panel at Outsourced Pharma San Francisco at this pivotal time for Achaogen,” said Larson. This open forum for discussion and learning between supply chain partners and drug sponsors is a unique opportunity to learn best practices and grow partnerships."
“We are honored to have Achaogen as our Spotlight Leadership Company at Outsourced Pharma San Francisco 2017,” said Garguilo. “Over the past year, I’ve had the pleasure of working directly with Tina Larson, who is a member of our Outsourced Pharma Editorial Board, and would like to thank her and the other Achaogen members for creating this session for our attendees. Learning from Achaogen about manufacturing outsourcing strategy, criteria for selecting supply chain partners, and developing effective long-term partnerships, will add to the knowledge of all our companies attending our San Francisco forum this year."
With this event in San Francisco, Outsourced Pharma enters its fourth year of hosting thought leadership conferences and exhibitions that provide discussions of best practices and practical applications of outsourcing skills, with an open format for panel and audience participation. This year’s conference in San Francisco is titled: Transference in Drug Development and Manufacturing Outsourcing. All Outsourced Pharma conferences provide opportunities for attendees to learn about specific aspects of biotechnology and pharmaceutical outsourcing, interact with a cross-section of industry members, and generate new business opportunities.
For the full agenda and speaker biographies, visit www.outsourcedpharmaevents.com.
Outsourced Pharma Conference and Exhibition Dates:
October 17-18, 2017 | San Francisco
About Outsourced Pharma Conference and Exhibition
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.
OutsourcedPharma.com provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.
About Life Science Connect
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.